End the Vaccine Carveout Act

# End the Vaccine Carveout Act Summary **What the Bill Would Do** The End the Vaccine Carveout Act (S. 3853) would remove special legal protections that vaccine manufacturers currently have under federal law. Specifically, it would eliminate provisions that shield vaccine makers from liability lawsuits when people claim vaccines have caused them harm. Currently, the National Vaccine Injury Compensation Program (VICP) is the primary mechanism for injured parties to seek compensation, rather than suing manufacturers directly in court. **Who It Affects and Key Implications** If passed, this bill would primarily affect vaccine manufacturers, who would face potential lawsuits from individuals claiming vaccine-related injuries.

It could also impact consumers, as manufacturers might respond by raising prices, limiting vaccine production, or withdrawing from the market—though supporters argue it would increase manufacturer accountability. The bill would change how vaccine injury claims are handled, shifting from the current no-fault compensation system to the traditional lawsuit approach used for other medications. **Current Status** The bill is currently in committee as of the 119th Congress, meaning it has not yet been voted on by the full Senate. It was introduced by Senator Rand Paul (R-KY).